Bloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier Dysfunction

被引:21
|
作者
Coburn, Phillip S. [1 ]
Wiskur, Brandt J. [2 ]
Miller, Frederick C. [3 ,4 ]
LaGrow, Austin L. [1 ]
Astley, Roger A. [1 ]
Elliott, Michael H. [1 ,2 ,5 ]
Callegan, Michelle C. [1 ,2 ,6 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Family & Preventat Med, Oklahoma City, OK USA
[5] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA
[6] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK USA
来源
PLOS ONE | 2016年 / 11卷 / 05期
基金
美国国家卫生研究院;
关键词
ENDOGENOUS BACTERIAL ENDOPHTHALMITIS; INTERCELLULAR-ADHESION MOLECULE-1; STAPHYLOCOCCUS-AUREUS; PIGMENT EPITHELIUM; SODIUM IODATE; KLEBSIELLA-PNEUMONIAE; VIRULENCE; PERMEABILITY; BREAKDOWN; NEOVASCULARIZATION;
D O I
10.1371/journal.pone.0154560
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The blood-retinal barrier (BRB) functions to maintain the immune privilege of the eye, which is necessary for normal vision. The outer BRB is formed by tightly-associated retinal pigment epithelial (RPE) cells which limit transport within the retinal environment, maintaining retinal function and viability. Retinal microvascular complications and RPE dysfunction resulting from diabetes and diabetic retinopathy cause permeability changes in the BRB that compromise barrier function. Diabetes is the major predisposing condition underlying endogenous bacterial endophthalmitis (EBE), a blinding intraocular infection resulting from bacterial invasion of the eye from the bloodstream. However, significant numbers of EBE cases occur in non-diabetics. In this work, we hypothesized that dysfunction of the outer BRB may be associated with EBE development. To disrupt the RPE component of the outer BRB in vivo, sodium iodate (NaIO3) was administered to C57BL/6J mice. NaIO3-treated and untreated mice were intravenously injected with 108 colony forming units (cfu) of Staphylococcus aureus or Klebsiella pneumoniae. At 4 and 6 days postinfection, EBE was observed in NaIO3-treated mice after infection with K. pneumoniae and S. aureus, although the incidence was higher following S. aureus infection. Invasion of the eye was observed in control mice following S. aureus infection, but not in control mice following K. pneumoniae infection. Immunohistochemistry and FITC-dextran conjugate transmigration assays of human RPE barriers after infection with an exoprotein-deficient agr/sar mutant of S. aureus suggested that S. aureus exoproteins may be required for the loss of the tight junction protein, ZO-1, and for permeability of this in vitro barrier. Our results support the clinical findings that for both pathogens, complications which result in BRB permeability increase the likelihood of bacterial transmigration from the bloodstream into the eye. For S. aureus, however, BRB permeability is not required for the development of EBE, but toxin production may facilitate EBE pathogenesis.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Organ-On-A-Chip Technologies for Advanced Blood-Retinal Barrier Models
    Ragelle, Heloise
    Goncalves, Andreia
    Kustermann, Stefan
    Antonetti, David A.
    Jayagopal, Ashwath
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (01) : 30 - 41
  • [32] Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy
    Rudraraju, Madhuri
    Narayanan, S. Priya
    Somanath, Payaningal R.
    PHARMACOLOGICAL RESEARCH, 2020, 161
  • [33] Protective Effect of Clusterin on Blood-Retinal Barrier Breakdown in Diabetic Retinopathy
    Kim, Jeong-Hun
    Kim, Jin Hyoung
    Yu, Young Suk
    Min, Bon Hong
    Kim, Kyu-Won
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (03) : 1659 - 1665
  • [34] TIM2 modulates retinal iron levels and is involved in blood-retinal barrier breakdown
    Valenca, Andreia
    Mendes-Jorge, Luisa
    Bonet, Aina
    Catita, Joana
    Ramos, David
    Jose-Cunilleras, Eduard
    Garcia, Miguel
    Carretero, Ana
    Nacher, Victor
    Navarro, Marc
    Ruberte, Jesus
    EXPERIMENTAL EYE RESEARCH, 2021, 202
  • [35] Permeability of the blood-retinal barrier in healthy humansEuropean concerted action on ocular fluorometry
    Hilderik J. Van Schaik
    Bernard Heintz
    Michael Larsen
    Eugenio Leite
    Vitor Rosas
    Rainer Schalnus
    Jaap A. Van Best
    Graefe's Archive for Clinical and Experimental Ophthalmology, 1997, 235 : 639 - 646
  • [36] Changes in blood-retinal barrier permeability in form deprivation myopia in tree shrews
    Kitaya, N
    Ishiko, S
    Abiko, T
    Mori, F
    Kagokawa, H
    Kojima, M
    Saito, K
    Yoshida, A
    VISION RESEARCH, 2000, 40 (17) : 2369 - 2377
  • [37] A Potential Role for Angiopoietin 2 in the Regulation of the Blood-Retinal Barrier in Diabetic Retinopathy
    Rangasamy, Sampathkumar
    Srinivasan, Ramprasad
    Maestas, Joann
    McGuire, Paul G.
    Das, Arup
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) : 3784 - 3791
  • [38] RETRACTED: Drug Flux Across RPE Cell Models: The Hunt for An Appropriate Outer Blood-Retinal Barrier Model for Use in Early Drug Discovery (Retracted Article)
    Hellinen, Laura
    Hongisto, Heidi
    Ramsay, Eva
    Kaarniranta, Kai
    Vellonen, Kati-Sisko
    Skottman, Heli
    Ruponen, Marika
    PHARMACEUTICS, 2020, 12 (02)
  • [39] Aquaporin expression in blood-retinal barrier cells during experimental autoimmune uveitis
    Motulsky, Elie
    Koch, Philippe
    Janssens, Sarah
    Lienart, Maite
    Vanbellinghen, Anne-Marie
    Bolaky, Nargis
    Chan, Chi-Chao
    Caspers, Laure
    Martin-Martinez, Maria-Dolores
    Xu, Heping
    Delporte, Christine
    Willermain, Francois
    MOLECULAR VISION, 2010, 16 (66-69): : 602 - 610
  • [40] Pigmented-MDCK (P-MDCK) Cell Line with Tunable Melanin Expression: An in Vitro Model for the Outer Blood-Retinal Barrier
    Kadam, Rajendra S.
    Scheinman, Robert I.
    Kompella, Uday B.
    MOLECULAR PHARMACEUTICS, 2012, 9 (11) : 3228 - 3235